MLICM
LNZA icon

Metropolitan Life Insurance Company (MetLife)’s LanzaTech LNZA Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio LNZA Stock Details LNZA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12
Closed -$5.72K – 2371
2023
Q3 		$5.72K Hold
12
– – ﹤0.01% 2385
2023
Q2 		$8.37K Buy
+12
New +$4.74K ﹤0.01% 2385

Other funds holding LNZA

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DI
DUMAC Inc Durham, North Carolina $1.1B AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s LNZA Position: Q4 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of LanzaTech (LNZA) in Q4 2023, closing a stake of 12 shares — an estimated $5.72K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in LNZA in Q2 2023 and held it in 2 quarters. The position peaked at $8.37K in Q2 2023. 62 funds tracked by Wall St. Rank hold LNZA as of Q4 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining LanzaTech position as of Q4 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 12 LanzaTech shares in Q4 2023, an estimated $5.72K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in LanzaTech in Q2 2023 and held it in 2 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s LanzaTech position peaked at $8.37K in Q2 2023.
  • 62 funds tracked by Wall St. Rank held LanzaTech as of Q4 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2023, filed 14 Feb 2024.